The human eye has a unique architecture and physiology compared to the other organs in the human body. As a result, it's tough to get the medicine into the target tissue. Because of the many obstacles and the nasolacrimal drainage of the medicine through tears, approximately 70% of the administered drug was drained out throughout the examination process. Due to insufficient dosage reaching the tissue, desired therapeutic benefits were not achieved and sometimes harmful outcomes were caused consequently, a dosage form must be created that provides the needed therapeutic cut comes. It was necessary to develop an in-situ gelling device in order to address the numerous difficulties associated with the administration of ocular drugs. Gels that change from a liquid to a gel when exposed as physiological cues including temperature, pH, and ionic strength are called in-situ gels. They witch w a reversible sol-gel-sol phase. This attribute of In situ gel extends their time in the eye as their vicinity rises, and they are made from muco-adhesive polymers. They are created. They're completely clear there's no risk of blurry eyesight.

In situ-gel, Eye, OFX, gelation